Quest Diagnostics Reports Third Quarter 2021 Financial Results, Raises Outlook for Full Year 2021

Go back to Quest Diagnostics Reports Third Quarter 2021 Financial Results, Raises Outlook for Full Year 2021

Quest Diagnostics (DGX) Tops Q3 EPS by $1.29; Raises Outlook

October 21, 2021 6:48 AM EDT

Quest Diagnostics (NYSE: DGX) reported Q3 EPS of $3.96, $1.29 better than the analyst estimate of $2.67. Revenue for the quarter came in at $2.77 billion versus the consensus estimate of $2.42 billion.

"We had a strong third quarter, as COVID-19 molecular volumes increased throughout the summer... More